The invention belongs to the field of chemical medicines, and particularly relates to a combined
medicine for preventing and / or treating prostatic
cancer, application of the combined
medicine and a
medicine composition. The combined medicine disclosed by the invention comprises immune cells with enhanced infiltration degree and a
galectin-1 inhibitor; the immune cells with enhanced infiltration degree are natural killer (NK) cells with TTTY15-USP9Y chimera
RNA knocked out, the infiltration degree and anti-tumor activity of the NK cells in a
prostate cancer microenvironment can be improved, and the activated NK cells have a stronger killing effect on
tumor cells in vitro. The immune cells with enhanced infiltration degree and the
galectin-1 inhibitor are combined for use, so that the composition shows a synergistic effect in treatment of prostatic
cancer, and has a wide application prospect.